We are live on
!
Find out more
IC
IEQ Capital Portfolio holdings
AUM
$21.5B
1-Year Est. Return
75.26%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+75.26%
3 Year Est. Return
+200.43%
5 Year Est. Return
+196.91%
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
+$644M
(+15%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
981
New
89
Increased
388
Reduced
336
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$47.1M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$47M |
| 3 |
Roblox
RBLX
|
+$27.7M |
| 4 |
Joby Aviation
JOBY
|
+$15.4M |
| 5 |
Apple
AAPL
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$12.8M |
| 2 |
CrowdStrike
CRWD
|
+$9.9M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$7.59M |
| 4 |
Silicon Laboratories
SLAB
|
+$7.54M |
| 5 |
Penumbra
PEN
|
+$7.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Communication Services | 13.07% |
| 3 | Consumer Discretionary | 6.86% |
| 4 | Healthcare | 6.72% |
| 5 | Financials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
226
DELISTED
Splunk Inc
SPLK
| $2.58M | 0.05% |
24,321
+284
| +1% | +$27K |
|
227
iShares MSCI ACWI ex US ETF
ACWX
$11.7B
| $2.57M | 0.05% |
52,280
+20
| +0% | +$985 |
|
228
iShares Core S&P Mid-Cap ETF
IJH
$126B
| $2.53M | 0.05% |
48,450
+165
| +0.3% | +$8.2K |
|
229
Microchip Technology
MCHP
$43.4B
| $2.53M | 0.05% |
28,276
-2,731
| -9% | -$215K |
|
230
MSCI
MSCI
$41.8B
| $2.53M | 0.05% |
5,386
+35
| +0.7% | +$17.1K |
|
231
Moody's
MCO
$83.8B
| $2.52M | 0.05% |
7,253
-201
| -3% | -$63.7K |
|
232
PagerDuty
PD
$854M
| $2.48M | 0.05% |
110,428
-1,102
| -1% | -$30.6K |
|
233
McKesson
MCK
$97.5B
| $2.46M | 0.05% |
5,746
+411
| +8% | +$158K |
|
234
SLB Ltd
SLB
$74.9B
| $2.44M | 0.05% |
49,611
+7,667
| +18% | +$366K |
|
235
Regeneron Pharmaceuticals
REGN
$78.3B
| $2.4M | 0.05% |
3,346
+73
| +2% | +$56.3K |
|
|
ETV
236
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.76B
| $2.4M | 0.05% |
+187,894
| New | +$2.33M |
|
237
RB Global
RBA
$20.8B
| $2.38M | 0.05% |
39,698
+19,848
| +100% | +$1.12M |
|
238
Colgate-Palmolive
CL
$72.9B
| $2.38M | 0.05% |
30,857
-1,420
| -4% | -$110K |
|
239
iShares US Technology ETF
IYW
$25B
| $2.38M | 0.05% |
21,817
+12,299
| +129% | +$1.21M |
|
240
Marriott International
MAR
$89.6B
| $2.36M | 0.05% |
12,871
+1,920
| +18% | +$333K |
|
241
Vanguard Morningstar Value ETF
VTV
$191B
| $2.36M | 0.05% |
16,615
-72
| -0.4% | -$10K |
|
242
iShares MSCI EAFE Value ETF
EFV
$29.1B
| $2.36M | 0.05% |
48,196
+1,241
| +3% | +$61.1K |
|
243
Avantis Emerging Markets Equity ETF
AVEM
$26.3B
| $2.36M | 0.05% |
43,821
+18,971
| +76% | +$1.01M |
|
244
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $2.33M | 0.05% |
17,576
+8,603
| +96% | +$1.13M |
|
|
ATVI
245
DELISTED
Activision Blizzard
ATVI
| $2.29M | 0.05% |
27,111
+1,254
| +5% | +$101K |
|
246
Robinhood
HOOD
$83.7B
| $2.27M | 0.05% |
227,189
| – | – |
|
247
State Street Energy Select Sector SPDR ETF
XLE
$38.3B
| $2.26M | 0.05% |
55,600
-1,900
| -3% | -$77.4K |
|
248
RH
RH
$3.58B
| $2.25M | 0.05% |
6,820
+326
| +5% | +$85.2K |
|
249
Charter Communications
CHTR
$17.7B
| $2.24M | 0.05% |
6,110
-1,577
| -21% | -$538K |
|
250
Hilton Worldwide
HLT
$70.5B
| $2.23M | 0.05% |
15,314
+1,952
| +15% | +$278K |
|
Similar funds
DSA
MMH
AM
VARA
SC
BA
IEQ Capital's Q2 2023 Portfolio in Review
As of Q2 2023, IEQ Capital held 981 positions worth $4.96B, up 15% from $4.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
IEQ Capital deployed $171M of net new capital in Q2 2023, opening 89 new positions and adding to 388 existing holdings. Its largest new stake was Neurocrine Biosciences: 481,268 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Salesforce, an estimated $12.8M trimmed.
- IEQ Capital's largest Q2 2023 buy was Neurocrine Biosciences: 481,268 shares worth $45.4M.
- IEQ Capital added most to Upbound Group in Q2 2023, an estimated $47.1M increase.
- IEQ Capital's biggest Q2 2023 reduction was Salesforce, cutting an estimated $12.8M.
- IEQ Capital fully exited Penumbra in Q2 2023, selling an estimated $7.08M.
- IEQ Capital's ten largest holdings make up 38% of its $4.96B portfolio in Q2 2023.
- IEQ Capital opened 89 new positions and closed 81 in Q2 2023.
- IEQ Capital's portfolio value rose 15% quarter-over-quarter to $4.96B.
Based on IEQ Capital's 13F filing for Q2 2023, filed 8 Aug 2023.